BIOA (Bioage Labs) Buyback Yield % : -148.24 (As of Apr. 23, 2025)

View and export this data going back to 2024. Start your Free Trial

What is Bioage Labs Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Bioage Labs's current buyback yield was -148.24%.

Bioage Labs Buyback Yield % Historical Data

The historical data trend for Bioage Labs's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioage Labs Buyback Yield % Chart

Bioage Labs Annual Data

Trend

Dec22

Dec23

Dec24

Buyback Yield %

-106.77

Bioage Labs Quarterly Data
	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Buyback Yield %	Get a 7-Day Free Trial				-	-	-	-	-106.77

Competitive Comparison of Bioage Labs's Buyback Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Bioage Labs's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bioage Labs's Buyback Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bioage Labs's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Bioage Labs's Buyback Yield % falls into.

Save Embed

;

Save Embed

;

Bioage Labs Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Bioage Labs's Buyback Yield for the fiscal year that ended in Dec. 2024 is calculated as

Buyback Yield	=	Net Issuance of Stock			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	/	Market Cap
	=	- (0	+	221.619)	/	207.5715
	=	-106.77%

Bioage Labs's annualized Buyback Yield for the quarter that ended in Dec. 2024 is calculated as

Buyback Yield	=	Net Issuance of Stock		(TTM)		/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	(TTM)^**	/	Market Cap
	=	- (0	+	221.619)		/	207.5715
	=	-106.77%

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Bioage Labs Buyback Yield % Related Terms

Thank you for viewing the detailed overview of Bioage Labs's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioage Labs Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bioage Labs Inc (NAS:BIOA) » Definitions » Buyback Yield %

Comparable Companies

Traded in Other Exchanges

Y7G:Germany

Address

1445A South 50th Street, Richmond, CA, USA, 94804

Website

https://www.bioagelabs.com

Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.